NewBiologix operates as a technology innovation company.
NewBiologix has raised $50.3M in total funding. The most recent round was Series A. The last funding was announced in May 2023.
NewBiologix's investors include Recipharm Venture Fund, Igor Fish, Nicolas Mermod.
NewBiologix is headquartered in Epalinges, Switzerland.
NewBiologix operates as a technology innovation company.
NewBiologix is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NewBiologix — Funding & Investors." VCBacked, May 11, 2023, https://www.vcbacked.co/company/newbiologix. Accessed September 30, 2026.
VCBacked. (2023). NewBiologix — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/newbiologix
{{cite web |title=NewBiologix — Funding & Investors |url=https://www.vcbacked.co/company/newbiologix |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated